EX-10.1
from 8-K
156 pages
Amended and Restated Credit Agreement Dated as of January 7, 2016 Among Sagent Pharmaceuticals, as U.S. Borrower Omega Laboratories Limited, as Canadian Borrower the Lenders Party Hereto and Jpmorgan Chase Bank, N.A., as the Administrative Agent J.P. Morgan Securities LLC, as Sole Bookrunner and Sole Lead Arranger Chase Business Credit
12/34/56
EX-10.2
from 8-K
15 pages
Joinder and Amendment No. 1 Regarding Credit Agreement Dated as of September 26, 2011 Among Sagent Pharmaceuticals and Sagent Pharmaceuticals, Inc. Each as Borrower and Collectively as Borrowers and Midcap Funding III, LLC, as Agent and as a Lender and the Additional Lenders From Time to Time Party Thereto Originally Dated as of March 8, 2011 Joinder and Amendment No. 1 Regarding Credit Agreement
12/34/56
EX-10.1
from 8-K
15 pages
Joinder and Amendment No. 6 Regarding Credit Agreement Dated as of September 26, 2011 Among Sagent Pharmaceuticals and Sagent Pharmaceuticals, Inc. Each as Borrower and Collectively as Borrowers and Midcap Funding IV, LLC, as Agent and as a Lender and the Additional Lenders From Time to Time Party Thereto Originally Dated as of June 16, 2009 Joinder and Amendment No. 6 Regarding Credit Agreement
12/34/56